Nanomol Technologies, S.L. delivers advanced solutions to obtain high-added value products by particle technologies and nanoformulation. We offer our Proprietary Platforms for the formulation of innovative functional materials, together with advanced cGMP particle characterization services.
Nanomol Technologies was Founded in 2010 by academic researchers from Materials Science Institute of Barcelona — CSIC, having wide expertise and recognized excellence in the synthesis, processing, and study of molecular functional materials.
Located in the Barcelona Autonomous University Research Park, Nanomol is provided with excellent interaction with scientific technical services, academic research groups and biotech, pharmaceutical and chemical companies. Nanomol Technologies has developed and commercializes DELOS proprietary platforms, useful to innovate, develop or improve new and existing products in areas like pharmaceuticals, cosmetics, biocides and medical devices.
Innovation by particle design on pharma, biotech and healthcare products.
Advanced technology platforms producing particles with outstanding properties.
High-added value particle characterization services for analysis of raw materials (APIs), intermediates, final products.
Passionate about development and characterization of nanomedicines and particulate products.
High quality development and analysis services by following GMP, ICH, Ph.Eur., USP, ISO guidelines and standards.
Experienced and highly qualified team to become your best R+D partner.
Commitment towards environmental and social needs, through technologies focused to generate better health care products in a clean and responsible manner.
Technology Transfer & Business Development DirectorLinkedin
Particle Analysis Unit ManagerLinkedin
Quality Assurance ManagerLinkedin
Analytical Development ScientistLinkedin
Quality Assurance Deputy ManagerLinkedin
Scientist, Development & Tech TransferLinkedin
Dr. Lidia Ferrer is R&D Director of Nanomol Technologies SL and responsible for the design, monitoring and evaluation of experimental activities in our research projects, aiming to develop new nanomedicines and active ingredient reformulations. She received her PhD in Chemistry from the Autonomous University of Barcelona (UAB). She is expert in development, functionalization and physicochemical characterization on Small Unilamellar Vesicles (SUVs) and nanoliposomes. She holds as well vast experience in HPLC analytical development.
Dr. Alba Córdoba is Business Development Director and coordinator of Technology Transfer and scale-up activities. She holds a BEng in Chemical Engineering, Postgraduate in Technology Transfer and Innovation Management and a PhD in Chemical Science and Technology. Alba brings more than 10 years of experience in applied R&D, industry-academy collaboration and IP Management in micro and nanostructured materials and biomaterials for health applications.
Òscar Raposo is Particle Analysis Unit Manager. He is in charge of the supervision of measurements under costumer’s requirements and GMP compliance. He was graduated as Materials Engineer from the University of Barcelona and he completed the Master's Degree in Advanced Nanoscience and Nanotechnology at the Autonomous University of Barcelona. With a wide knowledge in Particle Size Distribution analysis, he manages Developments and Validations of analytical methods.
Josep Merlo is Process Engineer of Nanomol Technologies S.L. He works on the scaling-up of our technologies for the production of nanoformulations and nanomedicines from lab to GMP pilot and commercial scale. He is graduated in Chemical Engineering at Institut Químic de Sarrià and MSc in same field (Chemical Engineering) at Universidad Politécnica de Madrid. In addition to process engineering activities, he is also in charge of the implementation of the Quality by Design approach in product development activities.
Teresa Manich is Quality Assurance Manager of Nanomol Technologies S.L. As QA Manager she is responsible of the implementation, maintenance and continuous improvement of Nanomol Technologies quality policies. Graduated in Pharmacy and having completed the postgraduate course of Pharmaceutical Quality Implementation: GLP-GMP, ISO and Validations in Pharmaceutical Industry at Universitat de Barcelona, she is provided with solid experience in GMP quality system and quality assurance, as well as analytical techniques including HPLC.
Carla Castellar is Lab Manager and R&D scientist of Nanomol Technologies S.L. She is graduated in Biomedicine and has completed a Master of Science in Biotechnology at Universitat de Barcelona. As a Lab manager, Carla coordinates and supervises the analysis and the development and validation of analytical methods under GMP compliance. She also collaborates in company Research Projects devoted to the development of new nanomedicines and particulate materials. Carla is currently enrolled in an Industrial PhD, in collaboration with the Materials Science Institute of Barcelona (ICMAB-CSIC).
Marta Alcaina is R&D Scientist at Nanomol Technologies S.L. As part of the R&D team, she participates in different research projects devoted to the development and characterization of nanoformulations based on our DELOS technology. She is graduated in Biochemistry and she has an MSc in Biotechnology from the Universitat Autònoma de Barcelona (UAB). Marta is currently enrolled in an Industrial PhD, in collaboration with the Materials Science Institute of Barcelona (ICMAB-CSIC), focused on the development of new nanovesicular systems for healthcare applications. Besides, she is qualified as particle size analyst.
Arnau Güell is R&D Scientist at Nanomol Technologies S.L. He is graduated in Nanoscience and Nanotechnology from the Universitat Autònoma de Barcelona (UAB) and he has an MSc in Biomedical Engineering from the Universitat de Barcelona (UB). He is currently in charge of the analytical development for the characterization of new nanomedicines by HPLC, and he also collaborates in the development of new nanomedicines and active ingredient reformulations on the base of the proprietary technology of the company.
Júlia Mengibar Heras is Laboratory Analyst at the Particle Characterization Unit of Nanomol Technologies S.L. She is in charge of carrying out sample studies in terms of particle characterization, as well as physicochemical and HPLC analysis. She contributes as well to the development and validation of analytical methods under GMP compliance. She holds a higher professional degree in Laboratory Operations, Analysis and Quality Control, and she is currently a Chemistry student at the Universidad Nacional de Educación a Distancia (UNED).
Estela Álvarez is Laboratory Analyst at the Particle Characterization Unit of Nanomol Technologies S.L. She holds a higher professional degree in Laboratory Operations, Analysis and Quality Control. She is in charge of carrying out physicochemical characterization of nano and micro particulate products, including the development and validation of analytical methods under GMP compliance. She is also professionally trained in Administration and Finance and thus, owing to the duality of her studies, she performs several administrative tasks in the company.
Yolanda Ronda, one of our scientists in our Particle Characterization Unit. Yolanda participates in the physicochemical characterization of micro and nano particles in drug substances and drug products. She also supports more complex characterization studies and the DELOS business unit, focused on the development of nanomedicines. Yolanda studied Biotechnology at the University of Lleida and did her Master in Research, Control and Development of Medicines at the University of Barcelona.
Laura Gonzalez, our Quality Assurance Deputy Manager at Nanomol Technologies S.L. She has a degree in Pharmacy and has specialized in Pharmaceutical Quality Systems. She also holds a PhD in Materials Science from the Autonomous University of Barcelona. Laura has a solid background in nanomedicine R&D and is an expert with more than 6 years in quality management in the pharmaceutical industry in compliance with GMP.
Xavier Castellví Corrons, our Scientist, Development & Tech Transfer, enrolled in our DELOS business unit to participate in the characterization, development, and technology transfer of robust nanomedicines. Xavier holds a bachelor’s degree in Nanoscience and Nanotechnology, a master’s degree in Biomedicine, and an MSCA industrial PhD in Physical Chemistry. He brings a broad knowledge of colloidal and encapsulation systems for research applications as well as several years of research experience in international environments.
Dr. Santi Sala is CEO and cofounder of Nanomol Technologies SL and heads finance, business development, marketing & sales and strategy divisions. He is former Research Associate at CIBER-BBN. PhD in Chemistry at the Autonomous University of Barcelona and MBA for Barcelona School of Management - Pompeu Fabra University. Expert in particle design for drug delivery and Nanomedicine, as well as in physico-chemical characterization of particles. Vast experience in management and commercialization of research & development results and derived Intellectual Property.
Prof. Jaume Veciana is Senior Scientific Consultant of Nanomol Technologies SL and cofounder of the company. He is Research Professor of the Institute of Materials Science of Barcelona (ICMAB-CSIC), Director of the Molecular Nanoscience and Organic Materials Department (MNOM) and Co-director of Nanomol group belonging to the TECNIO network. He is the Scientific Director of NANBIOSIS ICTS infrastructure at CIBER-BBN. He is an internationally recognized scientist in the field of functional molecular materials with more than 400 journal articles and book chapters and 15 patents.
Dr. Nora Ventosa is Senior Scientific Consultant of Nanomol Technologies SL and cofounder of the company. She is Scientific Researcher of the Institute of Materials Science of Barcelona (ICMAB-CSIC) and affiliated researcher of CIBER-BBN. Co-director of the Nanomol group belonging to the TECNIO network. Chair of Knowledge and Technology Transfer by UAB Research Park and Santander Bank. Scientist expert on design, synthesis, characterization and study of new supramolecular materials for nanomedicine with more than 60 papers in peer reviewed journals and 5 licensed international patents.